Absci Corp SEC filings ABSI
Absci Corp has 360 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2025 | — |
| EFFECT | Filing | Apr 10, 2025 | — |
| CORRESP | Letter to the SEC | Apr 8, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 1, 2023 | — |
| CORRESP | Letter to the SEC | May 24, 2023 | — |
| UPLOAD | Letter from the SEC | May 15, 2023 | — |
| EFFECT | Filing | Sep 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 31, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2022 | — |
| EFFECT | Filing | Jul 21, 2021 | — |
| CERT | Filing | Jul 21, 2021 | — |
| 8-A12B | Filing | Jul 21, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 20, 2021 | — |
| CORRESP | Letter to the SEC | Jul 20, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2021 | — |
| CORRESP | Letter to the SEC | Jul 19, 2021 | — |
| CORRESP | Letter to the SEC | Jul 19, 2021 | — |
| CORRESP | Letter to the SEC | Jul 19, 2021 | — |
| CORRESP | Letter to the SEC | Jul 15, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2021 | — |
| SEC STAFF LETTER | Filing | Jul 8, 2021 | — |
| CORRESP | Letter to the SEC | Jul 8, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2021 | — |
| DRS/A | Filing | Jun 16, 2021 | — |
| DRSLTR | Filing | Jun 15, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2021 | — |
| DRS | Filing | May 6, 2021 | — |
| D | Filing | Mar 30, 2021 | — |
| D/A | Filing | Mar 30, 2021 | — |
| D/A | Filing | Feb 26, 2021 | — |
| D | Filing | Oct 30, 2020 | — |
| D | Filing | Dec 19, 2019 | — |
| D | Filing | Jun 8, 2018 | — |
| D | Filing | Apr 21, 2016 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- ABSI (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Vancouver, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1672688
- Former names
- AbSci, LLC (until Dec 19, 2019)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- OmniAb, Inc. OABI
- NRC Health NRC
- Maxcyte, Inc. MXCT
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.